世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Monoclonal Antibody Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3910
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、モノクローナル抗体治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん、自己免疫疾患、感染症、造血系疾患、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・モノクローナル抗体治療の市場動向
・企業の競争状況、市場シェア
・モノクローナル抗体治療の種類別市場規模（がん、自己免疫疾患、感染症、造血系疾患、その他）
・モノクローナル抗体治療の用途別市場規模（病院、クリニック、その他）
・モノクローナル抗体治療の北米市場規模2016-2027（アメリカ、カナダ）
・モノクローナル抗体治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・モノクローナル抗体治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・モノクローナル抗体治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・モノクローナル抗体治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Bayer、Sanofi、Merck、GlaxoSmithKline、Roche、Novartis、AbbVie）
・結論

For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.

Market Analysis and Insights: Global Monoclonal Antibody Treatment Market
The global Monoclonal Antibody Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Monoclonal Antibody Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Monoclonal Antibody Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Monoclonal Antibody Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Monoclonal Antibody Treatment market.

Global Monoclonal Antibody Treatment Scope and Market Size
Monoclonal Antibody Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Bayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cancer
1.2.3 Autoimmune Diseases
1.2.4 Infection
1.2.5 Hematological Diseases
1.2.6 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Monoclonal Antibody Treatment Market Perspective (2016-2027)
2.2 Monoclonal Antibody Treatment Growth Trends by Regions
2.2.1 Monoclonal Antibody Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monoclonal Antibody Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Monoclonal Antibody Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Monoclonal Antibody Treatment Industry Dynamic
2.3.1 Monoclonal Antibody Treatment Market Trends
2.3.2 Monoclonal Antibody Treatment Market Drivers
2.3.3 Monoclonal Antibody Treatment Market Challenges
2.3.4 Monoclonal Antibody Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Treatment Players by Revenue
3.1.1 Global Top Monoclonal Antibody Treatment Players by Revenue (2016-2021)
3.1.2 Global Monoclonal Antibody Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Treatment Revenue
3.4 Global Monoclonal Antibody Treatment Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Treatment Revenue in 2020
3.5 Monoclonal Antibody Treatment Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Treatment Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Monoclonal Antibody Treatment Breakdown Data by Type
4.1 Global Monoclonal Antibody Treatment Historic Market Size by Type (2016-2021)
4.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2022-2027)

5 Monoclonal Antibody Treatment Breakdown Data by Application
5.1 Global Monoclonal Antibody Treatment Historic Market Size by Application (2016-2021)
5.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Monoclonal Antibody Treatment Market Size (2016-2027)
6.2 North America Monoclonal Antibody Treatment Market Size by Type
6.2.1 North America Monoclonal Antibody Treatment Market Size by Type (2016-2021)
6.2.2 North America Monoclonal Antibody Treatment Market Size by Type (2022-2027)
6.2.3 North America Monoclonal Antibody Treatment Market Size by Type (2016-2027)
6.3 North America Monoclonal Antibody Treatment Market Size by Application
6.3.1 North America Monoclonal Antibody Treatment Market Size by Application (2016-2021)
6.3.2 North America Monoclonal Antibody Treatment Market Size by Application (2022-2027)
6.3.3 North America Monoclonal Antibody Treatment Market Size by Application (2016-2027)
6.4 North America Monoclonal Antibody Treatment Market Size by Country
6.4.1 North America Monoclonal Antibody Treatment Market Size by Country (2016-2021)
6.4.2 North America Monoclonal Antibody Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Monoclonal Antibody Treatment Market Size (2016-2027)
7.2 Europe Monoclonal Antibody Treatment Market Size by Type
7.2.1 Europe Monoclonal Antibody Treatment Market Size by Type (2016-2021)
7.2.2 Europe Monoclonal Antibody Treatment Market Size by Type (2022-2027)
7.2.3 Europe Monoclonal Antibody Treatment Market Size by Type (2016-2027)
7.3 Europe Monoclonal Antibody Treatment Market Size by Application
7.3.1 Europe Monoclonal Antibody Treatment Market Size by Application (2016-2021)
7.3.2 Europe Monoclonal Antibody Treatment Market Size by Application (2022-2027)
7.3.3 Europe Monoclonal Antibody Treatment Market Size by Application (2016-2027)
7.4 Europe Monoclonal Antibody Treatment Market Size by Country
7.4.1 Europe Monoclonal Antibody Treatment Market Size by Country (2016-2021)
7.4.2 Europe Monoclonal Antibody Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Treatment Market Size (2016-2027)
8.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type
8.2.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application
8.3.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region
8.4.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Monoclonal Antibody Treatment Market Size (2016-2027)
9.2 Latin America Monoclonal Antibody Treatment Market Size by Type
9.2.1 Latin America Monoclonal Antibody Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Monoclonal Antibody Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Monoclonal Antibody Treatment Market Size by Type (2016-2027)
9.3 Latin America Monoclonal Antibody Treatment Market Size by Application
9.3.1 Latin America Monoclonal Antibody Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Monoclonal Antibody Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Monoclonal Antibody Treatment Market Size by Application (2016-2027)
9.4 Latin America Monoclonal Antibody Treatment Market Size by Country
9.4.1 Latin America Monoclonal Antibody Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Monoclonal Antibody Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Treatment Market Size (2016-2027)
10.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type
10.2.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application
10.3.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country
10.4.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Monoclonal Antibody Treatment Introduction
11.1.4 Pfizer Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Monoclonal Antibody Treatment Introduction
11.2.4 Bayer Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Monoclonal Antibody Treatment Introduction
11.3.4 Sanofi Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Monoclonal Antibody Treatment Introduction
11.4.4 Merck Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Monoclonal Antibody Treatment Introduction
11.6.4 Roche Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Treatment Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Treatment Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.8.5 AbbVie Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Monoclonal Antibody Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cancer
Table 3. Key Players of Autoimmune Diseases
Table 4. Key Players of Infection
Table 5. Key Players of Hematological Diseases
Table 6. Key Players of Others
Table 7. Global Monoclonal Antibody Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Monoclonal Antibody Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Monoclonal Antibody Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Monoclonal Antibody Treatment Market Share by Regions (2016-2021)
Table 11. Global Monoclonal Antibody Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Monoclonal Antibody Treatment Market Share by Regions (2022-2027)
Table 13. Monoclonal Antibody Treatment Market Trends
Table 14. Monoclonal Antibody Treatment Market Drivers
Table 15. Monoclonal Antibody Treatment Market Challenges
Table 16. Monoclonal Antibody Treatment Market Restraints
Table 17. Global Monoclonal Antibody Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Monoclonal Antibody Treatment Market Share by Players (2016-2021)
Table 19. Global Top Monoclonal Antibody Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Treatment as of 2020)
Table 20. Ranking of Global Top Monoclonal Antibody Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Monoclonal Antibody Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Monoclonal Antibody Treatment Product Solution and Service
Table 24. Date of Enter into Monoclonal Antibody Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Monoclonal Antibody Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Monoclonal Antibody Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Monoclonal Antibody Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Monoclonal Antibody Treatment Product
Table 67. Pfizer Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Bayer Company Details
Table 70. Bayer Business Overview
Table 71. Bayer Monoclonal Antibody Treatment Product
Table 72. Bayer Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 73. Bayer Recent Development
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Monoclonal Antibody Treatment Product
Table 77. Sanofi Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Monoclonal Antibody Treatment Product
Table 82. Merck Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 83. Merck Recent Development
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Monoclonal Antibody Treatment Product
Table 87. GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 88. GlaxoSmithKline Recent Development
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Monoclonal Antibody Treatment Product
Table 92. Roche Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 93. Roche Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Monoclonal Antibody Treatment Product
Table 97. Novartis Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 98. Novartis Recent Development
Table 99. AbbVie Company Details
Table 100. AbbVie Business Overview
Table 101. AbbVie Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 102. AbbVie Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Treatment Market Share by Type: 2020 VS 2027
Figure 2. Cancer Features
Figure 3. Autoimmune Diseases Features
Figure 4. Infection Features
Figure 5. Hematological Diseases Features
Figure 6. Others Features
Figure 7. Global Monoclonal Antibody Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Monoclonal Antibody Treatment Report Years Considered
Figure 12. Global Monoclonal Antibody Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Monoclonal Antibody Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Monoclonal Antibody Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Monoclonal Antibody Treatment Market Share by Regions (2022-2027)
Figure 16. Global Monoclonal Antibody Treatment Market Share by Players in 2020
Figure 17. Global Top Monoclonal Antibody Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibody Treatment Revenue in 2020
Figure 19. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 23. North America Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 24. North America Monoclonal Antibody Treatment Market Share by Country (2016-2027)
Figure 25. United States Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 29. Europe Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 30. Europe Monoclonal Antibody Treatment Market Share by Country (2016-2027)
Figure 31. Germany Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Monoclonal Antibody Treatment Market Share by Region (2016-2027)
Figure 41. China Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Monoclonal Antibody Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Monoclonal Antibody Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 61. Bayer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 67. AbbVie Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3908 2021年4月 97Pages
QYResearch社発行の本調査資料では、モノクローナル抗体治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヒト化抗体、ヒトマウスキメラ抗体）、用途別市場規模（がん、自己免疫疾患、感染症、造血系疾患、眼科疾患、その他）、主要地域別市場規模...

世界のモノクローナル抗体療法市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z3909 2021年4月 97Pages
QYResearch社発行の本調査資料では、モノクローナル抗体療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヒトモノクローナル抗体、ヒト化モノクローナル抗体、キメラモノクローナル抗体、マウスモノクローナル抗体）、用途別市場規模（がん、自己...

世界のモノクローナル抗体製品市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Based Products Market Size, Status and Forecast 2021-2027
QYR2104Z3905 2021年4月 90Pages
QYResearch社発行の本調査資料では、モノクローナル抗体製品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん、自己免疫、炎症性、感染性、微生物性、ウイルス性疾患）、用途別市場規模（病院、研究、学術機関、診療所、診断研究所）、主要地域別...

世界のモノクローナル抗体作製サービス市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Custom Service Market Size, Status and Forecast 2021-2027
QYR2104Z3906 2021年4月 90Pages
QYResearch社発行の本調査資料では、モノクローナル抗体作製サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ラットカスタムモノクローナル抗体、ウサギカスタムモノクローナル抗体、その他）、用途別市場規模（病院、研究所、製薬・バイオテ...

世界のモノクローナル抗体サービス市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Service Market Size, Status and Forecast 2021-2027
QYR2104Z3907 2021年4月 134Pages
QYResearch社発行の本調査資料では、モノクローナル抗体サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬、医薬品、その他）、用途別市場規模（診断研究所、研究・学術研究所、製薬・バイオテクノロジー企業）、主要地域別市場規模（北米...

世界のモノクローナル抗体サービス市場規模・現状・予測（2021年-2027年）

世界のモノクローナルマウス抗体市場規模・現状・予測（2021年-2027年）

Global Monoclonal Mouse Antibody Market Size, Status and Forecast 2021-2027
QYR2104Z3911 2021年4月 129Pages
QYResearch社発行の本調査資料では、モノクローナルマウス抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（IgM、IgG、IgA、その他）、用途別市場規模（治療、研究、診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のモノクローナルマウス抗体市場規模・現状・予測（2021年-2027年）

世界のモノクローナル抗体治療市場 2021：企業別、地域別、種類・用途別

Global Monoclonal Antibody Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z09556 2021年4月 104Pages
当調査資料では、モノクローナル抗体治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。モノクローナル抗体治療の種類別市場規模（がん、自己免疫疾患、感染症、造血系疾患、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨー...

世界のヒト化抗体市場規模・現状・予測（2021年-2027年）

Global Antibody Humanization Market Size, Status and Forecast 2021-2027
QYR2104Z0373 2021年4月 92Pages
QYResearch社発行の本調査資料では、ヒト化抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、二重特異性抗体、CDRグラフト化抗体）、用途別市場規模（HIV、SARS、RSV、プリオン）、主要地域別市場規模（北米、ア...

世界のモノクローナル抗体治療市場 2021：企業別、地域別、種類・用途別 The Monoclonal Antibody Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Monoclonal Antibody Therapeutics Market The global Monoclonal Antibody Therapeutics market size is projected to reach US$ 178100 million by 2026, from US$ 109280 million in 2019, at a CAGR of 7.1% during 2021-2026. With industry-standard accuracy in analysis and …
世界のモノクローナル抗体製品市場規模・現状・予測（2021年-2027年） Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins. This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodie…
世界のモノクローナル抗体療法市場規模・現状・予測（2021年-2027年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
世界のモノクローナル抗体作製サービス市場規模・現状・予測（2021年-2027年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…